Dear Friends and Colleagues
It is with great excitement that we welcome you to the Congress on Cellular and Humoral Immunotherapy in Autoimmunity (CHIA), held in the beautiful city of Paris, France from September 18-20, 2025.
The field of immunotherapy is advancing rapidly, and this conference provides a vital platform for exploring the latest breakthroughs and emerging trends in both cellular and humoral immunotherapies, particularly in the context of autoimmune diseases. This year’s theme emphasizes bridging the gap between treatments for haematological malignancies and autoimmune disorders, highlighting the significant overlap and unique challenges shared by these fields.
Throughout the congress, we will have the privilege of hearing from leading experts, researchers, and clinicians who are at the forefront of developing new therapies and treatment strategies. With a combination of cutting-edge research presentations and engaging interactions, we aim to foster meaningful discussions about the most recent innovations, challenges, and breakthroughs in immunotherapy.
We are proud to present a comprehensive program featuring renowned speakers, each sharing their expertise on topics ranging from immune system modulation to the clinical applications of CAR T-cell therapy, T cell engagers, and B-cell lineage targeting in autoimmunity. These discussions will deepen our understanding and broaden the potential for more effective, personalized treatments.
Warm regards,
Dror Mevorach
CHIA Co-Chair
